Olanzapine for psychotic and behavioral disturbances in Alzheimer disease. - Test2 - elhamkhani - TriplyDB

Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.

Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.

http://www.wikidata.org/entity/Q35201061

about

Identifying unexpected therapeutic targets via chemical-protein interactome Atypical neuroleptics as a treatment of agitation and anxiety in Alzheimer's disease: risks or benefits.Predicting drug-disease associations by using similarity constrained matrix factorization.

P2860

Q28473107-2F350712-202B-485D-B3E8-47F99F13289D Q36492352-3C275B6D-F338-47F6-BB45-2092AA058DA1 Q55312446-6ADD6C99-4627-403F-B277-8E90DD1C03E5

P2860

Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.

http://www.wikidata.org/entity/Q35201061

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.

@ast

Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.

@en

type

label

Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.

@ast

Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.

@en

prefLabel

Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.

@ast

Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.

@en

P1433

Q35201061-F6DED75A-CA96-4703-BA12-DFF864D7BE4D

P1476

Q35201061-C3D46F16-B72B-4A5C-9E39-6CB1A5BF52EF

P2093

Q35201061-006016D5-D0AF-4FB9-A1CB-93A3D2B27D61

P2860

Q35201061-01AC9F6B-2763-4403-82D9-35FF26EB07D6

Q35201061-1390A7A1-5964-42F8-8189-7A59B5CC94F2

Q35201061-520BD234-F01E-4EEC-BF8D-0B92BC469485

Q35201061-566A7167-3011-4392-8E03-9CDB88B66A43

Q35201061-5D2F185C-F27C-468B-807E-A19D49A45859

Q35201061-615D581F-22E8-4B1D-98BD-5C882CF76C5A

Q35201061-816F234A-436D-40CD-9312-50EDE00FD27E

Q35201061-9B936161-EADA-4A15-B140-4E7D2BB9EA5E

Q35201061-D8CDE424-FC74-47A6-898D-74858BCC733D

Q35201061-F2457A60-25C3-48A0-9563-589B14A8D76A

P304

Q35201061-6A4EBDF2-D26C-41CD-BFB2-32AB2E27A975

P31

Q35201061-1E98E047-1B86-45C3-B40F-B3AD840B8277

P356

Q35201061-F8969BC8-445F-4743-AF58-EA46C48032E4

P407

Q35201061-347A6404-672E-4A2D-9A5A-2ABE113B85BD

P433

Q35201061-83450FE7-721C-4AA4-B769-A66728BBB022

P478

Q35201061-E92A54BA-DB63-4D1D-AAD7-668C28DC1AAD

P577

Q35201061-D0508680-9E8C-40B2-ADDD-F3F5E2D950E8

P698

Q35201061-45214AA9-E3B0-4EC1-A8D6-225F4271E686

P921

Q35201061-5570422D-19BF-4EC9-A1EA-3FCF3822C95D

Q35201061-7EB07CEE-B71D-42E1-A989-54172540A63B

P356

P1433

Annals of Pharmacotherapy

P1476

Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.

@en

P2093

Robin A Schatz

http://www.w3.org/2001/XMLSchema#string

P2860

A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data.

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging.

The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches.

A metaanalysis of controlled trials of neuroleptic treatment in dementia.

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.

The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's disease.

Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia.

Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis.

Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.

Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease.

P304

1321-1324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1D050

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12921516

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease